Literature DB >> 16167339

Translating the histone code into leukemia.

Bryan E Linggi1, Stephen J Brandt, Zu-Wen Sun, Scott W Hiebert.   

Abstract

The "histone code" is comprised of the covalent modifications of histone tails that function to regulate gene transcription. The post-translational modifications that occur in histones within the regulatory regions of genes include acetylation, methylation, phosphorylation, ubiquitination, sumoylation, and ADP-ribosylation. These modifications serve to alter chromatin structure and accessibility, and to act as docking sites for transcription factors or other histone modifying enzymes. Several of the factors that are disrupted by chromosomal translocations associated with hematological malignancies can alter the histone code in a gene-specific manner. Here, we discuss how the histone code may be disrupted by chromosomal translocations, either directly by altering the activity of histone modifying enzymes, or indirectly by recruitment of this type of enzyme by oncogenic transcription factors. These alterations in the histone code may alter gene expression pattern to set the stage for leukemogenesis. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16167339     DOI: 10.1002/jcb.20604

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  20 in total

1.  Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.

Authors:  Y Li; C Deng; X Hu; B Patel; X Fu; Y Qiu; M Brand; K Zhao; S Huang
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

2.  Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation.

Authors:  Brenda J Chyla; Isabel Moreno-Miralles; Melissa A Steapleton; Mary Ann Thompson; Srividya Bhaskara; Michael Engel; Scott W Hiebert
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

Review 3.  Leukaemogenesis: more than mutant genes.

Authors:  Jianjun Chen; Olatoyosi Odenike; Janet D Rowley
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

Review 4.  TCF/LEFs and Wnt signaling in the nucleus.

Authors:  Ken M Cadigan; Marian L Waterman
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

5.  Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression.

Authors:  Zhanxin Wang; Jikui Song; Thomas A Milne; Gang G Wang; Haitao Li; C David Allis; Dinshaw J Patel
Journal:  Cell       Date:  2010-06-10       Impact factor: 41.582

6.  Strong Correlation between the Expression Levels of HDAC4 and SIRT6 in Hematological Malignancies of the Adults.

Authors:  Zsuzsanna Gaál; Éva Oláh; László Rejtő; Ferenc Erdődi; László Csernoch
Journal:  Pathol Oncol Res       Date:  2016-10-20       Impact factor: 3.201

Review 7.  Breaking the histone code with quantitative mass spectrometry.

Authors:  Laura-Mae P Britton; Michelle Gonzales-Cope; Barry M Zee; Benjamin A Garcia
Journal:  Expert Rev Proteomics       Date:  2011-10       Impact factor: 3.940

8.  Myeloid translocation gene family members associate with T-cell factors (TCFs) and influence TCF-dependent transcription.

Authors:  Amy C Moore; Joseph M Amann; Christopher S Williams; Emilios Tahinci; Tiffany E Farmer; J Andres Martinez; Genyan Yang; K Scott Luce; Ethan Lee; Scott W Hiebert
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

9.  Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control.

Authors:  Srividya Bhaskara; Brenda J Chyla; Joseph M Amann; Sarah K Knutson; David Cortez; Zu-Wen Sun; Scott W Hiebert
Journal:  Mol Cell       Date:  2008-04-11       Impact factor: 17.970

10.  Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905.

Authors:  Thomas Prebet; Zhuoxin Sun; Maria E Figueroa; Rhett Ketterling; Ari Melnick; Peter L Greenberg; James Herman; Mark Juckett; Mitchell R Smith; Lisa Malick; Elisabeth Paietta; Magdalena Czader; Mark Litzow; Janice Gabrilove; Harry P Erba; Steven D Gore; Martin S Tallman
Journal:  J Clin Oncol       Date:  2014-03-24       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.